Requires disclosure of information about non-invasive prenatal screening for chromosomal abnormalities.

This bill mandates that health care providers disclose specific information about non-invasive prenatal screening for chromosomal abnormalities. The information must include the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).

Requires disclosure of information about non-invasive prenatal screening for chromosomal abnormalities.

This bill mandates that health care providers disclose specific information about non-invasive prenatal screening for chromosomal abnormalities. The information must include the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).